The Role of BRD4 in Cardiac Specification

BRD4 在心脏指标中的作用

基本信息

  • 批准号:
    10394203
  • 负责人:
  • 金额:
    $ 40.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-01 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Summary Statement Cardiovascular disease remains the leading cause of death in the United States. One emerging long-term strategy for patients with congestive heart failure focuses on cellular regeneration. Efforts include boosting the function of existing cardiac myocytes, introducing immature myocytes into failing hearts, and even introducing electrically insulated patches of myocardium. All of these efforts require a highly-detailed understanding of the molecular determinants that drive myocyte lineage specification and differentiation and the mechanistic basis by which these factors regulate lineage specific gene expression cascades. Landmark studies have revealed a critical role for the Bromodomain extraterminal domain (BET) protein Brd4 in regulating lineage specific gene programs by recognizing or reading areas of the genome marked by specific modifications. In addition, studies abrogating BET protein function in murine models of heart failure have demonstrated promising results, by modulating lineage specific function. However, the normal role of BET proteins, specifically Brd4, has not been elucidated during cardiac development. Our data implicates a critical role for Brd4 during cardiac development, specifically by transcriptionally activating genes poised for expression upon lineage adoption. We seek to define the exact programs activated by Brd4 during cardiac development. In addition, our studies seek to understand if cardiac progenitor cells are rendered vulnerable to adopting aberrant cell fates upon loss of activation cues (via loss of Brd4). Our work will provide essential insight into how Brd4 drives cardiac lineage specification, ultimately allowing for manipulation of this process to generate cell types of interest. Defining the molecular pathways which regulate myogenesis will undoubtedly shape emerging novel therapeutics and regenerative strategi
简要说明 心血管疾病仍然是美国的主要死亡原因。一个新兴的长期 充血性心力衰竭患者的治疗策略侧重于细胞再生。努力包括促进 现有的心肌细胞的功能,将未成熟的心肌细胞引入衰竭的心脏,甚至引入 电绝缘的心肌补片。所有这些努力都需要对 驱动肌细胞谱系特化和分化的分子决定因素及其机制基础 这些因子通过其调节谱系特异性基因表达级联。具有里程碑意义的研究表明, 溴结构域末端外结构域(BET)蛋白Brd4在调节谱系特异性基因中的关键作用 通过识别或阅读基因组中被特定修饰标记的区域来编程。另外研究 在心力衰竭的鼠模型中消除BET蛋白功能已经证明了有希望的结果, 调节谱系特异性功能。然而,BET蛋白,特别是Brd4的正常作用尚未被证实。 在心脏发育过程中阐明。我们的数据暗示Brd4在心脏发育过程中的关键作用, 特别是通过转录激活准备在谱系采用时表达的基因。我们寻求 定义心脏发育过程中Brd4激活的确切程序。此外,我们的研究旨在 了解心脏祖细胞是否容易在丧失功能后接受异常细胞命运。 激活线索(通过Brd4的丢失)。我们的工作将为Brd4如何驱动心脏谱系提供重要的见解 本发明提供了一种细胞培养方法,该方法可以用于特定的细胞类型,最终允许操纵该过程以产生感兴趣的细胞类型。定义 调节肌生成的分子途径无疑将形成新兴的新疗法, 再生策略

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure Pathogenesis.
染色质重塑驱动心力衰竭发病机制中的免疫成纤维细胞串扰。
  • DOI:
    10.1101/2023.01.06.522937
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Alexanian,Michael;Padmanabhan,Arun;Nishino,Tomohiro;Travers,JoshuaG;Ye,Lin;Lee,ClaraYoungna;Sadagopan,Nandhini;Huang,Yu;Pelonero,Angelo;Auclair,Kirsten;Zhu,Ada;Teran,BarbaraGonzalez;Flanigan,Will;Kim,CharisKee-Seon;Lumbao-C
  • 通讯作者:
    Lumbao-C
Landscape of Hopx expression in cells of the immune system.
  • DOI:
    10.1016/j.heliyon.2021.e08311
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Bourque J;Opejin A;Surnov A;Iberg CA;Gross C;Jain R;Epstein JA;Hawiger D
  • 通讯作者:
    Hawiger D
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rajan Jain其他文献

Rajan Jain的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rajan Jain', 18)}}的其他基金

Deciphering how 3D genome organization orchestrates cardiac cellular identity
解读 3D 基因组组织如何协调心脏细胞身份
  • 批准号:
    10574267
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
  • 批准号:
    10116703
  • 财政年份:
    2020
  • 资助金额:
    $ 40.25万
  • 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
  • 批准号:
    10473778
  • 财政年份:
    2020
  • 资助金额:
    $ 40.25万
  • 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
  • 批准号:
    10268225
  • 财政年份:
    2020
  • 资助金额:
    $ 40.25万
  • 项目类别:
Single-cell dissection of chromatin architecture mechanisms connecting pathologic instability and transcriptional silencing
连接病理不稳定和转录沉默的染色质结构机制的单细胞解剖
  • 批准号:
    10684727
  • 财政年份:
    2020
  • 资助金额:
    $ 40.25万
  • 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
  • 批准号:
    10248408
  • 财政年份:
    2019
  • 资助金额:
    $ 40.25万
  • 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
  • 批准号:
    10461144
  • 财政年份:
    2019
  • 资助金额:
    $ 40.25万
  • 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
  • 批准号:
    10020996
  • 财政年份:
    2019
  • 资助金额:
    $ 40.25万
  • 项目类别:
Decoding the bridges and barriers to cellular reprogramming and lineage identity
解码细胞重编程和谱系身份的桥梁和障碍
  • 批准号:
    9790532
  • 财政年份:
    2019
  • 资助金额:
    $ 40.25万
  • 项目类别:
Investigating the role of Hopx in cardiac progenitor proliferation
研究 Hopx 在心脏祖细胞增殖中的作用
  • 批准号:
    8566353
  • 财政年份:
    2013
  • 资助金额:
    $ 40.25万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.25万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 40.25万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了